C. Li

发表

Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer.

N. Weiss, K. Malone, J. Daling, 2001, Journal of the National Cancer Institute.

Anthropometric variables in relation to risk of breast cancer in middle-aged women.

J. Stanford, J. Daling, Christopher I. Li, 2000, International journal of epidemiology.

Re: Tamoxifen and contralateral breast cancer: the other side.

N. Weiss, K. Malone, J. Daling, 2001, Journal of the National Cancer Institute.

Age When Maximum Height Is Reached as a Risk Factor for Breast Cancer among Young U.S. Women

E. White, K. Malone, J. Daling, 1997, Epidemiology.

Should women with a family history of breast cancer avoid use of oral contraceptives?

M. Pike, G. Ursin, C. Li, 2000, Epidemiology.

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Heather Eliassen, Karen Canfell, Julian Peto, 2012, The Lancet. Oncology.

Differential patterns of allelic loss in estrogen receptor‐positive infiltrating lobular and ductal breast cancer

C I Li, P. Porter, L. Loo, 2008, Genes, chromosomes & cancer.

Clinical characteristics of different histologic types of breast cancer

J. Daling, C. Li, D. J. Uribe, 2005, British Journal of Cancer.

Epidemiologic and molecular risk factors for contralateral breast cancer among young women

P. Porter, K. Malone, J. Daling, 2003, British Journal of Cancer.

Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL® sample preparation

J. Delrow, P. Porter, C. Sather, 2011, Breast Cancer Research and Treatment.